Details
The membrane attack complex (MAC) plays a critical role in complement-mediated hemolysis and inflammasome activation. Complement component 9 (C9) is 1 of 5 late-acting proteins of complement that participate in the assembly and function of the MAC. C9 mediates the killing of pathogenic microorganisms (especially Neisseria meningitidis) and participates in the clearance of immune complexes. Patients with C9 deficiency have reduced serum C9 levels. C9 may be cleaved by thrombin to generate fragments C9a and C9b.
An anti-tag antibody is pre-coated onto the bottom of wells. After adding antigen or samples, Tagged-Capture antibody and HRP-conjugated detection antibody, a sandwich complex is formed in the solution. TMB acts as a HRP substrate, and the solution color will change from colorless to blue. A stop solution containing sulfuric acid turns the solution yellow. The color intensity is proportional to the quantity of bound protein, which is measurable at 450 nm with the correction wavelength set at 630 nm.
Intra-assay Precision (Precision within an assay) Three samples of known concentration were tested 8 times on one plate to assess intra-assay precision. Inter-assay Precision (Precision between assays) Three samples of known concentration were tested in 16 separate assays to assess inter-assay precision.
Intra-assay Precision
| Sample | n | Mean (ng/mL) | SD | CV% |
| 1 | 8 | 4.55 | 0.13 | 2.86 |
| 2 | 8 | 1.10 | 0.02 | 1.82 |
| 3 | 8 | 0.55 | 0.01 | 1.82 |
Inter-assay Precision
| Sample | n | Mean (ng/mL) | SD | CV% |
| 1 | 16 | 4.61 | 0.13 | 2.82 |
| 2 | 16 | 1.21 | 0.08 | 6.61 |
| 3 | 16 | 0.55 | 0.02 | 3.64 |
The recovery of human C9 spiked to three different levels throughout the range of the assay was evaluated.
| Sample Type | Average% of Expected | Range (%) | |
| Human plasma | 1:160,000 | 98 | 95-101 |
| Human milk | 1:800 | 105 | 101-109 |
To assess the linearity of the assay, samples were diluted with the appropriate Sample Diluent to produce samples with values within the dynamic range of the assay. (The human plasma was initially diluted 1:10,000. The human milk was initially diluted 1:50.)
| Human plasma | Human milk | ||
| 1:2 | Average% of Expected | 100 | 100 |
| Range (%) | - | - | |
| 1:4 | Average% of Expected | 100 | 102 |
| Range (%) | 99-101 | 100-105 | |
| 1:8 | Average% of Expected | 103 | 107 |
| Range (%) | 101-105 | 104-111 | |
| 1:16 | Average% of Expected | 105 | 108 |
| Range (%) | 104-106 | 101-115 |
This immunoassay is calibrated against a highly purified recombinant human C9 produced at Sunlong Medical™.
Ordering & shipping
Citations
Partial purchase records (0)
Leave a message
+86 0571 56623320
[email protected]
+86 18668110335

Scan Wechat Qrcode
